Healthcare provider profile · identity verified

Ahmet U. Demircioglu, M.D.

Internal Medicine · ST FRANCIS, WI · NPI 1114005642

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	643	151
Amlodipine Besylate	Amlodipine Besylate	473	105
Pantoprazole Sodium	Pantoprazole Sodium	427	90
Losartan Potassium	Losartan Potassium	366	90
Furosemide	Furosemide	351	85
Levothyroxine Sodium	Levothyroxine Sodium	339	81
Metoprolol Succinate	Metoprolol Succinate	274	76
Lisinopril	Lisinopril	270	72
Tizanidine Hcl	Tizanidine Hcl	256	73
Albuterol Sulfate Hfa	Albuterol Sulfate	255	78
Metformin Hcl	Metformin Hcl	252	63
Tamsulosin Hcl	Tamsulosin Hcl	236	57
Gabapentin	Gabapentin	229	56
Fluticasone Propionate	Fluticasone Propionate	203	69
Simvastatin	Simvastatin	203	46
Omeprazole	Omeprazole	198	50
Jardiance	Empagliflozin	195	44
Rosuvastatin Calcium	Rosuvastatin Calcium	182	57
Metoprolol Tartrate	Metoprolol Tartrate	181	48
Pravastatin Sodium	Pravastatin Sodium	169	34
Mirtazapine	Mirtazapine	166	33
Trazodone Hcl	Trazodone Hcl	162	28
Tramadol Hcl	Tramadol Hcl	155	45
Hydrochlorothiazide	Hydrochlorothiazide	154	39
Clopidogrel	Clopidogrel Bisulfate	142	28
Potassium Chloride	Potassium Chloride	137	31
Allopurinol	Allopurinol	133	33
Eliquis	Apixaban	119	34
Glimepiride	Glimepiride	118	31
Donepezil Hcl	Donepezil Hcl	112	23
Famotidine	Famotidine	109	25
Carvedilol	Carvedilol	108	29
Metformin Hcl Er	Metformin Hcl	101	26
Escitalopram Oxalate	Escitalopram Oxalate	95	22
Citalopram Hbr	Citalopram Hydrobromide	94	19
Breo Ellipta	Fluticasone/Vilanterol	91	17
Alendronate Sodium	Alendronate Sodium	88	24
Ozempic	Semaglutide	87	18
Ropinirole Hcl	Ropinirole Hcl	83	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	21
Sertraline Hcl	Sertraline Hcl	81	19
Meloxicam	Meloxicam	80	29
Linzess	Linaclotide	73	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	24
Hydroxyzine Hcl	Hydroxyzine Hcl	69	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	13
Prednisone	Prednisone	66	46
Pregabalin	Pregabalin	65	12
Venlafaxine Hcl Er	Venlafaxine Hcl	65	15
Doxazosin Mesylate	Doxazosin Mesylate	54	12
Finasteride	Finasteride	51	12
Doxycycline Monohydrate	Doxycycline Monohydrate	46	31
Ketoconazole	Ketoconazole	46	18
Duloxetine Hcl	Duloxetine Hcl	45	12
Warfarin Sodium	Warfarin Sodium	45	13
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Combivent Respimat	Ipratropium/Albuterol Sulfate	43	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	13
Amitriptyline Hcl	Amitriptyline Hcl	40	12
Memantine Hcl	Memantine Hcl	40	suppressed
Myrbetriq	Mirabegron	40	suppressed
Topiramate	Topiramate	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Bumetanide	Bumetanide	39	suppressed
Ventolin Hfa	Albuterol Sulfate	39	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Naproxen	Naproxen	37	11
Spironolactone	Spironolactone	37	suppressed
Celecoxib	Celecoxib	36	suppressed
Ipratropium Bromide	Ipratropium Bromide	36	16
Farxiga	Dapagliflozin Propanediol	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Colchicine	Colchicine	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Meclizine Hcl	Meclizine Hcl	32	15
Torsemide	Torsemide	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	12
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Valsartan	Valsartan	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Azithromycin	Azithromycin	26	20
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Atenolol	Atenolol	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Ondansetron Odt	Ondansetron	23	11
Rexulti	Brexpiprazole	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Baclofen	Baclofen	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Risperidone	Risperidone	21	suppressed
Cephalexin	Cephalexin	20	17
Enalapril Maleate	Enalapril Maleate	20	suppressed
Glipizide	Glipizide	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	11
Folic Acid	Folic Acid	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Aripiprazole	Aripiprazole	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Metolazone	Metolazone	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Armodafinil	Armodafinil	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Temazepam	Temazepam	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Clonidine	Clonidine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error